Search for: "Smith v. Hatch"
Results 41 - 60
of 85
Sorted by Relevance
|
Sort by Date
19 Sep 2013, 1:23 pm
They argue that this divide is exemplified by the the Supreme Court’s decision in NFIB v. [read post]
3 Dec 2010, 8:22 am
Smith, who successfully argued Lawrence v. [read post]
13 Dec 2013, 4:48 pm
In Allard v. [read post]
20 Dec 2007, 7:57 am
Kerrigan is a partner resident in the Philadelphia office of Reed Smith LLP. [read post]
15 Oct 2014, 9:01 pm
Smith and Church of Lukumi Babalu Aye v. [read post]
20 Jun 2021, 9:00 am
RFRA was spearheaded in the Senate by Republican Senator Orrin Hatch and Democratic Senator Ted Kennedy. [read post]
1 Dec 2008, 9:27 pm
U.S. 6th Circuit Court of Appeals, November 24, 2008 Smith v. [read post]
15 Apr 2011, 8:58 am
Disclosure v. [read post]
16 Nov 2010, 5:16 pm
Court of Appeals for the Sixth Circuit to file an amicus brief in the consolidated appeals of Smith v. [read post]
1 Oct 2020, 3:35 am
So for anyone whether you the only shortcut you may know is Ctrl C and Ctrl V. [read post]
21 Jan 2015, 6:39 am
RFRA was spearheaded in the Senate by Republican Senator Orrin Hatch and Democratic Senator Ted Kennedy. [read post]
31 Oct 2013, 5:00 am
This post is from the Reed Smith (and now we should add Cozen) side of the blog only, as Dechert is involved in the litigation to be discussed.You’ll have to forgive us – we’re weird that way – but we found the opinion in Carter v. [read post]
7 May 2012, 5:00 am
Smith & Nephew, Inc., 482 F.3d 1187, 1194 (9th Cir. 2007); Phelps v. [read post]
18 Jan 2013, 2:06 pm
This post is by the Reed Smith part of the blog only. [read post]
23 Dec 2011, 6:30 am
Prometheus Laboratories, Inc., on the counterclaim provision of the Hatch-Waxman Act in Caraco Pharmaceutical Laboratories, Ltd. v. [read post]
10 Sep 2013, 7:29 am
Following his defeat in Gonzales v. [read post]
27 Aug 2017, 10:01 pm
FTC v. [read post]
27 Aug 2017, 10:01 pm
FTC v. [read post]
28 Aug 2014, 7:27 am
The case is Franzman v. [read post]
16 Mar 2011, 3:50 am
(EFF) US: Inter-agency group takes on counterfeit pharmaceuticals (PatentlyBIOtech) US: Recent Hatch-Waxman scholarship suggests patent settlement and product hopping create a ‘lethal combination’; another article proposes a ‘Smith Barney approach’ to 180-day exclusivity (FDA Law Blog) US: Sen Harkin urges FDA to avoid delays of generic drug approvals (GenericsWeb) Products Actos (Pioglitazone) – US: Takeda files patent infringement complaint against… [read post]
